Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
450 Enrollment(s)
100 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Cancer
NOT_YET_RECRUITING
NCT07691489
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
27 Enrollment(s)
7 Study location(s)
INTERVENTIONAL (PHASE2)
Colorectal Cancer


Adenocarcinoma of the Colon


Adenocarcinoma of the Rectum
COMPLETED
NCT07610577
Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction
377,753 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Acute Myocardial Infarction (AMI)
RECRUITING
NCT07015697
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
76 Enrollment(s)
31 Study location(s)
INTERVENTIONAL (PHASE1)
Recurrent or Metastatic Solid Tumors
NOT_YET_RECRUITING
NCT07619365
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


Advanced Breast Cancer


Metastatic Breast Cancer
COMPLETED
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
17,095 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome
NOT_YET_RECRUITING
NCT07683754
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
200 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Advanced Breast Cancer


Metastatic Breast Cancer


HER2 Positive


HR Positive
ACTIVE_NOT_RECRUITING
NCT06578247
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
700 Enrollment(s)
284 Study location(s)
INTERVENTIONAL (PHASE3)
Leukemia